FDA Approved: EVEROLIMUS — Original Application (NorthStar RxLLC)

View source ↗

Summary

FDA approved NorthStar RxLLC's original application (ANDA) for Everolimus, a generic version of the mTOR inhibitor. The approval enables a generic option for Ev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Pancreatic Neuroendocrine Tumor
• Renal Cell Carcinoma
• Subependymal Giant Cell Astrocytoma
• Tuberous Sclerosis Complex-associated Renal Angiomyolipoma

Drugs mentioned

• Everolimus (everolimus)

Snippet

ORIG AP for EVEROLIMUS (EVEROLIMUS)